摘要
《柳叶刀肿瘤学》（Lancet Oncology）近期以专委会名义发表了专栏文章,提出并讨论了美国未来癌症研究的优先策略（优先事项）。本文介绍了该专栏文章的发表背景、所涉及的癌症研究的主要优先策略及其提出的实现这些优先策略的措施与时间节点。结合笔者几十年来癌症研究的实践,对中美癌症研究的过去和现状作初步点评。期待能对我国的肿瘤防控、重大项目的实施以及政策制定有所启迪和借鉴。
Lancet Oncology recently published a column article under the name of Special Committee,proposing and discussing the strategies（priorities） for future cancer research in the United States. In this paper the background of the article publication,the main priorities for cancer research,and the measures and metrics for implementing these priorities are introduced. Based on the author＇s cancer research practice in the past decades,this paper makes preliminary comments on the past and present situation of cancer research in China and the United States,with the hope that we might get enlightenment and use as reference from this column article,for the implementation of major projects and policy decision-making in the prevention and control of cancer in China.
作者
陈建国
CHEN Jian-guo1,2(1.Qidong Liver Cancer Institute,Qidong 226200, China;2. Nantong University Tumor Hospital / Institute, Nantong 226361, Chin)
出处
《中国肿瘤》
CAS
CSCD
北大核心
2018年第5期321-327,共7页
China Cancer
